Kennedy E, Coulter E, Halliwell E, et al. TLR9 expression in chronic lymphocytic leukemia identifies a promigratory subpopulation and novel therapeutic target. Blood. 2021;137(22):3064-3078.

Page 3067: In “Materials and methods,” in the first sentence under the subheading “TLR9 activation and inhibition of CLL cells,” “5 μg/mL interleukin-4 [RayBiotech]” should read “5 ng/mL interleukin-4 [RayBiotech].”